Patent intelligence · US
US 11931338
Nitrilated psilocybin derivatives and methods of using
Nitrilated psilocybin derivatives and methods of using
Patent details — US 11931338
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 19, 2024
- Expiration
- Mar 14, 2044
- Applicant
- Enveric Biosciences Canada Inc.
- Claims
- 23
- CPC classes
- A61K, A61K31/4045, A61P, A61P25/00
Quick answer
US 11931338 (Nitrilated psilocybin derivatives and methods of using) is held by Enveric Biosciences Canada Inc.. Status: granted. Granted Mar 19, 2024. Expires Mar 14, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Enveric Biosciences Canada Inc.
- Grant date
- Expiration
- Claims
- 23
- CPC classes
- A61K, A61K31/4045, A61P, A61P25/00
More from Enveric Biosciences Canada Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12428408
Fused heterocyclic mescaline derivatives
granted -
US 12378195
Aminated psilocybin derivatives and methods of using
granted -
US 12358885
Substituted n-propylamine fused heterocyclic mescaline derivatives
granted -
US 12338231
N-heterocycle substituted tryptamine derivatives and methods of using
granted -
US 12195439
C1-substituted isopropylamine fused heterocyclic mescaline derivatives
granted -
US 12187679
Hydroxylated psilocybin derivatives and methods of using
granted -
US 12138276
Halogenated psilocybin derivatives and methods of using
granted -
US 12133856
Multi-substituent psilocybin derivatives and methods of using
granted
Frequently asked questions
What is US patent 11931338?
US 11931338 (Nitrilated psilocybin derivatives and methods of using) is held by Enveric Biosciences Canada Inc.. Status: granted. Granted Mar 19, 2024. Expires Mar 14, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11931338?
Enveric Biosciences Canada Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 22 pharmaceutical patents for this assignee.
When does US 11931338 expire?
Our index shows an expiration date of Mar 14, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.